共 4 条
[1]
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial[J] . Stevo Julius,Sverre E Kjeldsen,Michael Weber,Hans R Brunner,Steffan Ekman,Lennart Hansson,Tsushung Hua,John Laragh,Gordon T McInnes,Lada Mitchell,Francis Plat,Anthony Schork,Beverly Smith,Alberto Zanchetti.The Lancet . 2004 (9426)
[2]
Microalbuminuria Reduction With Valsartan in Patients With Type 2 Diabetes Mellitus: A Blood Pressure–Independent Effect[J] . Giancarlo Viberti,Nigel M. Wheeldon.Circulation: Journal of the American Heart Association . 2002 (6)
[3]
Angiotensin-Converting Enzyme Inhibitors and Kidney Protection: The AIPRI Trial[J] . G. Maschio,D. Alberti,F. Locatelli,J. F. E. Mann,M. Motolese,C. Ponticelli,E. Ritz,G. Janin,P. Zucchelli.Journal of Cardiovascular Pharmacology . 1999
[4]
Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial[J] . Piero Ruggenenti,Annalisa Perna,Giulia Gherardi,Flavio Gaspari,Roberto Benini,Giuseppe Remuzzi.The Lancet . 1998 (9136)